12 April 2024
Prof. Dr. Katrin Scheinemann Appointed Section Editor-in-Chief of Section “Childhood, Adolescent and Young Adult Oncology” in Current Oncology
We are pleased to announce that Prof. Dr. Katrin Scheinemann has been appointed Section Editor-in-Chief of the Section “Childhood, Adolescent and Young Adult Oncology” in Current Oncology (ISSN: 1718-7729). Prof. Dr. med. Katrin Scheinemann is a pediatric oncologist/hematologist from Switzerland. She is the division head of oncology/hematology at the Children’s Hospital of Eastern Switzerland in St. Gallen and a professor at the Faculty of Health Sciences and Medicine at the University of Lucerne, Switzerland. The focus of her research lies in the area of survivorship care in pediatric oncology and pediatric neuro-oncology. She has published over 100 papers in peer-reviewed journals so far and has edited two textbooks. She also holds many national and international positions as the treasurer and a board member of SIOPE (European Society for Pediatric Oncology), the chair of the SIOPE BTG (brain tumor group), and the chair of PanCare (multidisciplinary pan-European network of professionals, survivors, and their families working on long-term follow-up care for European childhood cancer survivors).
The following is a short Q&A with Prof. Dr. Katrin Scheinemann, who has shared her vision for the journal's advancement and impact, the promising future of oncology research, and her positive view on the development of open access in the publishing field:
1. What appealed to you about the journal that made you want to take the role as its Section Editor-in-Chief?
The journey with Current Oncology: from just submitting a manuscript as an author to becoming an Editor of a Special Issue and now Section Editor-in-Chief in the field that I am so passionate about. But clearly also your support—thank you!
2. What is your vision for the journal?
Overall, to increase the impact factor and develop it into one of the top journals in the oncology field. But also to give adolescent and young adult (AYA) cancer other publication options, as there are not so many dedicated ones (we have only three journals focusing on pediatric cancer to my knowledge).
3. What does the future of this field of childhood, adolescent and young adult oncology look like?
From my point of view, very promising. Within 50 years, the survival rate of a few percent is now long-term well over 80% in high-income countries. I hope that we can improve survival rates in developing countries as well, and that with newer treatments (immunotherapy, targeted therapy) we will see less disabling long-term late effects.
4. What do you think of the development of open access in the publishing field?
As only 20% of all pediatric and adolescent cancer diagnoses are made in high-income countries with all the resources available, open access can help a lot to improve survival rates and care in developing countries. The downside (in my view as a submitting author) is the fees, which are challenging to get covered from any research funding.
We wish Prof. Dr. Katrin Scheinemann every success in her position as Section Editor-in-Chief, and we look forward to her future contributions to the journal.
